Clinical trial · Interventional
Effect of Pneumoperitoneum on Remifentanil Requirements in the Surgical Pleth Index-guided Analgesia
Effect of Pneumoperitoneum on Remifentanil Requirements in the Surgical Pleth Index-guided Analgesia for Laparoscopic Gastrectomy
NCT03788447CI-TRIAL-00049331completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary purpose of this study is to investigate the effect of pneumoperitoneum on remifentanil requirements in the surgical pleth index-guided analgesia for laparoscopic gastrectomy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| High end-tidal CO2 | Other | — | UNRESOLVED |
| Low CO2 group | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- High CO2 group
- description
- end tidal CO2 : 40-45 mmHg
- interventionNames
- Other: High end-tidal CO2
- type
- PLACEBO_COMPARATOR
- label
- Low CO2 group
- description
- end tidal CO2 : 30-35 mmHg
- interventionNames
- Other: Low CO2 group
Primary outcomes (1)
- measure
- total dose of remifentanil
- timeFrame
- through study completion, an average of 2 hours
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * laparoscopic gastrectomy under general anesthesia Exclusion Criteria: * atypical hemoglobin disease, infective state, cardiovascular disease, peripheral vascular disease
References
Publications (0)
Data not yet available
No reference posted for this study.